A detailed history of Carr Financial Group Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Carr Financial Group Corp holds 2,393 shares of NVO stock, worth $202,088. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,393
Previous 2,100 13.95%
Holding current value
$202,088
Previous $250 Million 17.68%
% of portfolio
0.06%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

BUY
$85.0 - $120.04 $24,905 - $35,171
293 Added 13.95%
2,393 $206 Million
Q3 2024

Nov 01, 2024

BUY
$119.07 - $145.42 $12,026 - $14,687
101 Added 5.05%
2,100 $250 Million
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $52,888 - $63,318
431 Added 27.49%
1,999 $285 Million
Q1 2024

Apr 25, 2024

BUY
$102.11 - $135.92 $160,108 - $213,122
1,568 New
1,568 $201 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $191B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Carr Financial Group Corp Portfolio

Follow Carr Financial Group Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carr Financial Group Corp, based on Form 13F filings with the SEC.

News

Stay updated on Carr Financial Group Corp with notifications on news.